Release Date: 31/08/10 14:46 Summary: TMA FY10 Preliminary Final Report ASX appendix 4E Price Sensitive: Yes Download Document 57.44KB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling